ARTICLE | Clinical News
Prograf tacrolimus regulatory update
February 18, 2008 8:00 AM UTC
Astellas disclosed that in November, it submitted an application to EMEA for Prograf tacrolimus granules to prevent organ rejection in organ transplant patients. The company markets capsule and inject...